Abstract
An empirical approach to the concentration-time history of a dissolving drug has resulted in a cube-root equation in which the characteristic constant of the equation embodies the important physical variables of the system. This expression has been used to study the dissolution of a drug that degrades simultaneously in the test solution. An alternative representation of the dissolution process is first-order kinetics. These two approaches are compared by fitting the experimental data of the dissolution of digoxin and melphalan tablets in various media, and a new method for the proper analysis of data for the dissolution of tablets that simultaneously degrade in the test solution is presented.
Similar content being viewed by others
References
J. T. Carstensen. InPharmaceutics of Solids and Solid Dosage Forms, Wiley, New York, 1977.
K. G. Nelson and K. W. Miller. Principles of drug dissolution and absorption related to bioavailability. In J. Blanchard, R. J. Sawchuk, and B. B. Brodie (eds.),Principles and Perspectives in Drug Bioavailability, Karger, Basel, 1979, pp. 20–58.
S. A. H. Khalil and S. El-Masry. The instability of digoxin during the U.S.P. dissolution test of the tablets.J. Pharm. Pharmacol. 28:6P (1976).
T. S. Gaginella, P. G. Welling, and P. Bass. Nicotine base permeation through silicone elastomers: comparison of dimethylpolysiloxane and trifluoropropylmethylpolysiloxane systems,J. Pharm. Sci. 63:1849–1853 (1974).
J. G. Wagner. Interpretation of percent dissolved-time plots derived fromin vitro testing of conventional tablets and capsules,J. Pharm. Sci. 58:1253–1257 (1969).
F. Langenbucher. Linearization of dissolution rate curves by the Weibull distribution.J. Pharm. Pharmcol. 24:979–981 (1972).
K. G. Nelson and L. Y. Wang. Determination of time course of tablet disintegration I: numerical method,J. Pharm. Sci. 66:1758–1761 (1977).
K. G. Nelson and L. Y. Wang. Determination of time course of tablet disintegration II: method using continuous function.J. Pharm. Sci. 67:86–89 (1978).
J. T. Carstensen, J. L. Wright, K. W. Blessel, and J. Sheridan. U.S.P. dissolution test II: sigmoid dissolution profiles from directly compressed tablets.J. Pharm. Sci. 67:48–50 (1978).
J. T. Carstensen, J. L. Wright, K. W. Blessel, and J. Sheridan. U.S.P. dissolution test III: semilogarithmic dissolution patterns of tablets in rotating-basket assemblies.J. Pharm. Sci. 67:982–984 (1978).
J. T. Carstensen, T. Y.-F. Lai and V. K. Prasad. U.S.P. dissolution IV: comparison of methods.J. Pharm. Sci. 67:1303–1307 (1978).
S. Y. Chang, D. S. Alberts, L. R. Melnick, P. D. Walson, and S. E. Salmon. High-pressure liquid Chromatographie analysis of melphalan in plasma.J. Pharm. Sci. 67:679–682 (1978).
S. A. H. Khalil and S. El-Masry. Instability of digoxin in acid medium using a nonisotopic method.J. Pharm. Sci. 67:1358–1360 (1978).
C. M. Metzler. Tech. Rep. 7292/69/7292/'005, Upjohn Co., Kalamazoo, Mich., 1969.
S. Y. Chang, D. S. Alberts, D. Farquhar, L. R. Melnick, P. D. Walson, and S. E. Salmon. Hydrolysis and protein binding of melphalan.J. Pharm. Sci. 67:682–684 (1978).
D. P. Vaughan and R. H. Leach. Simple transformation method for predicting plasma drug profiles from dissolution rates.J. Pharm. Sci. 65:601–603 (1976).
L. J. Aarons and M. Rowland. Use ofin vitro dissolution data to predict plasma drug profiles.J. Pharm. Sci. 66:1359–1362 (1977).
D. S. Alberts, S. Y. Chang, H-S. Chen, J. F. Gross, P. D. Walson, T. E. Moon, and S. E. Salmon. Variability of melphalan (M) absorption in man,Proc. AACR and ASCO, 19, Abstract No. C-112, 1978, p. 334.
O. R. McIntyre, L. Leone, and T. F. Pajak. The use of intravenous melphalan (L-PAM) in the treatment of multiple myeloma,Blood 52 (No. 5, suppl. 1):274 (1978).
D. J. Greenblatt, T. W. Smith, and J. Koch-Weser. Bioavailability of drugs: the digoxin dilemma.Clin. Pharmacokin. 1:36–51 (1976).
D. H. Huffman, C. V. Manion, and D. L. Azarnoff. Intersubject variation in absorption of digoxin in normal volunteers.J. Pharm. Sci. 64:433–437 (1975).
L. Lindenbaum, M. H. Mellon, M. O. Blackstone, and V. P. Butler. Variation in biologic availability of digoxin from four preparations.N. Engl. J. Med. 285:1344–1347 (1971).
D. H. Huffman and D. L. Azarnoff. Absorption of orally given digoxin preparations.J. Am. Med. Assoc. 222:957–960 (1972).
S. Y. Chang, T. L. Evans, and D. S. Alberts. The stability of melphalan in the presence of chloride ion.J. Pharm. Pharmacol. 31:853–854 (1979).
L. A. Sternson and R. D. Shaffer. Kinetics of digoxin stability in aqueous solution.J. Pharm. Sci. 67:327–330 (1978).
Author information
Authors and Affiliations
Additional information
This work was supported by Grant CA-17094 from the National Cancer Institute, and a donation by Burroughs Wellcome Company, Research Triangle Park, North Carolina.
Rights and permissions
About this article
Cite this article
Chen, H.S.G., Chang, S.Y., Evans, T.L. et al. Concentration profile for the dissolution of drug tablets undergoing simultaneous degradation. Journal of Pharmacokinetics and Biopharmaceutics 8, 621–631 (1980). https://doi.org/10.1007/BF01060057
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01060057